Once upon a time, botulinum toxin was used to simply help people who had strabismus, or crossed eyes. But as is the case with some of the most brilliant medical innovations, doctors noticed that wrinkles between the eyes, aka the 11-lines or glabella, were disappearing with treatment. Botox, as we know it, was a happy accident. Fast forward to today, and using FDA-approved neuromodulators (think: Botox, Dysport, Jeauveau, and Xeomin) for cosmetic purposes is common practice—and innovation is at an all-time high. Most recently, a new neuromodulator called Daxxify received the FDA’s stamp of approval.
“Daxxify is a neuromodulator to relax dynamic muscle movement to reduce lines caused by facial expression,” explains board-certified dermatologist at Schweiger Dermatology Dr. Brian Hibler. “It’s similar to other neuromodulators, such as Botox, Dysport, Xeomin, and Jeuveau, however, it is coated with peptide which helps it bind faster and stay in place longer.”
